August 2009 Volume 44 Number 3, pp 137 - 204
---------------------------------------------------------------------
The CliniMACS(R) Cell Separation System,
http://links.ealert.nature.com/ctt?kn=53&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
based on MACS(R) Technology,
http://links.ealert.nature.com/ctt?kn=5&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
enables the operator to perform clinical-scale magnetic separation of
target cells or depletion of unwanted cells.
---------------------------------------------------------------------
Announcing the NEW Bone Marrow Transplantation impact factor:
3.400*
20/62 in Hematology
39/121 in Immunology
54/141 in Oncology
6/21 in Transplantation
*2008 Journal Citation Report (Thomson Reuters, 2009)
http://links.ealert.nature.com/ctt?kn=7&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=61&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
to start your subscription today.
----------------------
REVIEW
----------------------
Hematopoietic stem cell transplantation for pediatric autoimmune disease:
where we stand and where we need to go
A C Krauss and N R Kamani
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=60&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan
in children undergoing reduced-intensity conditioning stem cell transplant
W T Tse, R Duerst, J Schneiderman, S Chaudhury, D Jacobsohn and M Kletzel
Abstract: http://links.ealert.nature.com/ctt?kn=66&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=40&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
BU and CY as conditioning regimen for autologous transplant in patients
with multiple myeloma
G Talamo, D F Claxton, D W Dougherty, C W Ehmann, J Sivik, J J Drabick
and W Rybka
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Short and long-term safety of lenograstim administration in healthy
peripheral haematopoietic progenitor cell donors: a single centre
experience
M Martino, G Console, A Dattola, I Callea, G Messina, T Moscato, E Massara,
G Irrera, R Fedele, A Gervasi, G Bresolin and P Iacopino
Abstract: http://links.ealert.nature.com/ctt?kn=59&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=67&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation
(allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia
patients
M J Burke, B Trotz, X Luo, D J Weisdorf, K S Baker, J E Wagner and M R Verneris
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=8&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Characterization of hemopoietic engraftment kinetics and development of secondary
cytopenia in AML post auto-SCT and its correlation with survival outcome
A S Babatunde, D C L Tan, K K Heng, J J Lee, Y S M Loh, W Y K Hwang, M B C Koh,
Y T Goh and Y C Linn
Abstract: http://links.ealert.nature.com/ctt?kn=23&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT
M Schmidt-Hieber, S Schwarck, A Stroux, E Thiel, S Ganepola, L Uharek and
I W Blau
Abstract: http://links.ealert.nature.com/ctt?kn=30&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=35&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
EBV-associated post transplant lymphoproliferative disorder of the `loser'
graft cell origin following double unrelated umbilical cord blood transplantation
R Hassan, C G Stefanoff, S Maradei, G A Fernandes, M H M Barros, F N Carestiato,
S O Romano, L F Bouzas and I R Zalcberg
http://links.ealert.nature.com/ctt?kn=27&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Clinical evidence for a graft-versus-tumour effect following allogeneic
HSCT for t(8;13) atypical myeloproliferative disorder
W Townsend, N C P Cross, K Waghorn, K Somana, A Ramsay, K Thomson and
K Peggs
http://links.ealert.nature.com/ctt?kn=19&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Pseudoaneurysm in the muscular artery of the right gluteal region following
a BM harvest
B A McGregor, D W Ririe and M B Osswald
http://links.ealert.nature.com/ctt?kn=42&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
Transfer of donor immune thrombocytopenic purpura to a recipient of an allogeneic
haematopoietic stem cell graft
B Avramova, M Yordanova, H G Heuft, L Arseniev and D Bobev
http://links.ealert.nature.com/ctt?kn=62&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
---------------------------------------------------------------------
Vaccine Strategies in the 21st Century
ICB: Special Feature & Web Focus
Immunology & Cell Biology, http://links.ealert.nature.com/ctt?kn=34&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
is proud to present Vaccine Strategies in the 21st Century - a collection
of articles that introduce research on a new generation of vaccines which
are logically designed and evaluated. The accompanying web focus delves
deeper into vaccine research, placing recent discoveries into context.
Access Vaccine Strategies in the 21st Century online today!
http://links.ealert.nature.com/ctt?kn=38&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=24&m=33852186&r=MTc1NjE0NTQ4OQS2&b=2&j=NTY1OTYyMTIS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
